Founded in Albany in 1991 as Albany Molecular Research, Curia is a global contract research, development and manufacturing organization serving pharmaceutical and biotechnology companies from drug discovery through commercial production. The company now operates an integrated network of more than 20 facilities across North America, Europe and India, with more than 3,000 professionals supporting small-molecule and biologics programs. Curia’s history includes discovery and development of the active pharmaceutical ingredient in Allegra and deep experience scaling complex APIs, sterile drug products and biologics.
ISO 13485:2016
ISO 9001:2015
Current Good Manufacturing Practices (cGMP)
Compliance program
FDA Drug Establishment Registration
Registration
California Drug Manufacturing License
Registration
MHRA Investigational Medicinal Products Authorization
Registration
DEA Registration for Schedule III Controlled Substances
Registration
Home Office Registration for Schedule I–V Controlled Substances
Registration
CONTROLLEDSUBSTANCESREGISTRATION
Quality certification
Ajinomoto Bio-Pharma ServicesWith more than 40 years in small-molecule manufacturing, Ajinomoto Bio-Pharma Services develops and produces pharmaceutical APIs and intermediates for drug companies worldwide. Its CDMO capabilities span the path from preclinical work through commercialization, while on-site analytical laboratories characterize molecules and support quality testing throughout their life cycle. Through Forge Biologics, a member of Ajinomoto Bio-Pharma Services, the company also provides AAV and plasmid manufacturing from preclinical through commercial stages.COLUMBUS, OH
Almac GroupWith more than 55 years of experience, Almac Group is a global partner to biopharma companies developing medicines for patients worldwide. From its Northern Ireland base, the group provides pharmaceutical development and manufacturing support across the drug-development lifecycle, with a particular strength in scaling solid oral-dose products from clinical work into commercial production.SOUDERTON, PA
Pharmaceutics International, Inc. (Pii)Founded in 1994, Pharmaceutics International, Inc. (Pii) is a Hunt Valley drug product contract development and manufacturing organization that takes pharmaceutical products from early development through clinical trials and commercial production. Now part of Jabil, Pii combines more than 30 years of complex-formulation experience with a 360,000-square-foot, four-site campus and more than 300 scientists and support staff. Its GMP facilities are built for demanding work, including potent compounds, complex injectables and oral drug products, with FDA-licensed and DEA-registered operations.HUNT VALLEY, MD
ActylisWith more than 75 years in the trade, Actylis sources and manufactures critical ingredients and raw materials for pharmaceutical, biopharmaceutical, nutrition and specialty-chemical makers. Its global network combines in-house production with tailored sourcing, process development and supply-chain support, including a 30,000-square-foot cGMP API facility in Eugene and Water for Injection capabilities in Montreal. Actylis operates ISO 9001:2015-certified facilities and supports customers from early development through commercial-scale production.GRAND ISLAND, NY